The global market for Transdermal Analgesics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Transdermal Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Transdermal Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Transdermal Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Transdermal Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Transdermal Analgesics players cover Abbott Laboratories, AbbVie Inc., Bayer AG, Eli Lilly and Company and endo pharmaceuticals, Glaxosmithkline plc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Transdermal Analgesics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Transdermal Analgesics market, with both quantitative and qualitative data, to help readers understand how the Transdermal Analgesics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Transdermal Analgesics market and forecasts the market size by Type (Non opioids and Opioids,), by Application (Hospital, Pharmacy and Family,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Non opioids
Opioids
Segmentation by application
Hospital
Pharmacy
Family
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott Laboratories
AbbVie Inc.
Bayer AG
Eli Lilly and Company
endo pharmaceuticals, Glaxosmithkline plc
johnson and johnson md&d
Pfizer, Inc.
Reckitt Benckiser Group
Sanofi
Chapter Introduction
Chapter 1: Scope of Transdermal Analgesics, Research Methodology, etc.
Chapter 2: Executive Summary, global Transdermal Analgesics market size (sales and revenue) and CAGR, Transdermal Analgesics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Transdermal Analgesics sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Transdermal Analgesics sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Transdermal Analgesics market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Abbott Laboratories, AbbVie Inc., Bayer AG, Eli Lilly and Company, endo pharmaceuticals, Glaxosmithkline plc, johnson and johnson md&d, Pfizer, Inc., Reckitt Benckiser Group and Sanofi, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Analgesics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Transdermal Analgesics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Transdermal Analgesics by Country/Region, 2017, 2022 & 2028
2.2 Transdermal Analgesics Segment by Type
2.2.1 Non opioids
2.2.2 Opioids
2.3 Transdermal Analgesics Sales by Type
2.3.1 Global Transdermal Analgesics Sales Market Share by Type (2017-2022)
2.3.2 Global Transdermal Analgesics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Transdermal Analgesics Sale Price by Type (2017-2022)
2.4 Transdermal Analgesics Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Family
2.5 Transdermal Analgesics Sales by Application
2.5.1 Global Transdermal Analgesics Sale Market Share by Application (2017-2022)
2.5.2 Global Transdermal Analgesics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Transdermal Analgesics Sale Price by Application (2017-2022)
3 Global Transdermal Analgesics by Company
3.1 Global Transdermal Analgesics Breakdown Data by Company
3.1.1 Global Transdermal Analgesics Annual Sales by Company (2020-2022)
3.1.2 Global Transdermal Analgesics Sales Market Share by Company (2020-2022)
3.2 Global Transdermal Analgesics Annual Revenue by Company (2020-2022)
3.2.1 Global Transdermal Analgesics Revenue by Company (2020-2022)
3.2.2 Global Transdermal Analgesics Revenue Market Share by Company (2020-2022)
3.3 Global Transdermal Analgesics Sale Price by Company
3.4 Key Manufacturers Transdermal Analgesics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transdermal Analgesics Product Location Distribution
3.4.2 Players Transdermal Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Transdermal Analgesics by Geographic Region
4.1 World Historic Transdermal Analgesics Market Size by Geographic Region (2017-2022)
4.1.1 Global Transdermal Analgesics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Transdermal Analgesics Annual Revenue by Geographic Region
4.2 World Historic Transdermal Analgesics Market Size by Country/Region (2017-2022)
4.2.1 Global Transdermal Analgesics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Transdermal Analgesics Annual Revenue by Country/Region
4.3 Americas Transdermal Analgesics Sales Growth
4.4 APAC Transdermal Analgesics Sales Growth
4.5 Europe Transdermal Analgesics Sales Growth
4.6 Middle East & Africa Transdermal Analgesics Sales Growth
5 Americas
5.1 Americas Transdermal Analgesics Sales by Country
5.1.1 Americas Transdermal Analgesics Sales by Country (2017-2022)
5.1.2 Americas Transdermal Analgesics Revenue by Country (2017-2022)
5.2 Americas Transdermal Analgesics Sales by Type
5.3 Americas Transdermal Analgesics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transdermal Analgesics Sales by Region
6.1.1 APAC Transdermal Analgesics Sales by Region (2017-2022)
6.1.2 APAC Transdermal Analgesics Revenue by Region (2017-2022)
6.2 APAC Transdermal Analgesics Sales by Type
6.3 APAC Transdermal Analgesics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transdermal Analgesics by Country
7.1.1 Europe Transdermal Analgesics Sales by Country (2017-2022)
7.1.2 Europe Transdermal Analgesics Revenue by Country (2017-2022)
7.2 Europe Transdermal Analgesics Sales by Type
7.3 Europe Transdermal Analgesics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Analgesics by Country
8.1.1 Middle East & Africa Transdermal Analgesics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Transdermal Analgesics Revenue by Country (2017-2022)
8.2 Middle East & Africa Transdermal Analgesics Sales by Type
8.3 Middle East & Africa Transdermal Analgesics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transdermal Analgesics
10.3 Manufacturing Process Analysis of Transdermal Analgesics
10.4 Industry Chain Structure of Transdermal Analgesics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transdermal Analgesics Distributors
11.3 Transdermal Analgesics Customer
12 World Forecast Review for Transdermal Analgesics by Geographic Region
12.1 Global Transdermal Analgesics Market Size Forecast by Region
12.1.1 Global Transdermal Analgesics Forecast by Region (2023-2028)
12.1.2 Global Transdermal Analgesics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transdermal Analgesics Forecast by Type
12.7 Global Transdermal Analgesics Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Transdermal Analgesics Product Offered
13.1.3 Abbott Laboratories Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 AbbVie Inc.
13.2.1 AbbVie Inc. Company Information
13.2.2 AbbVie Inc. Transdermal Analgesics Product Offered
13.2.3 AbbVie Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AbbVie Inc. Main Business Overview
13.2.5 AbbVie Inc. Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Transdermal Analgesics Product Offered
13.3.3 Bayer AG Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Transdermal Analgesics Product Offered
13.4.3 Eli Lilly and Company Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 endo pharmaceuticals, Glaxosmithkline plc
13.5.1 endo pharmaceuticals, Glaxosmithkline plc Company Information
13.5.2 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Product Offered
13.5.3 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 endo pharmaceuticals, Glaxosmithkline plc Main Business Overview
13.5.5 endo pharmaceuticals, Glaxosmithkline plc Latest Developments
13.6 johnson and johnson md&d
13.6.1 johnson and johnson md&d Company Information
13.6.2 johnson and johnson md&d Transdermal Analgesics Product Offered
13.6.3 johnson and johnson md&d Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 johnson and johnson md&d Main Business Overview
13.6.5 johnson and johnson md&d Latest Developments
13.7 Pfizer, Inc.
13.7.1 Pfizer, Inc. Company Information
13.7.2 Pfizer, Inc. Transdermal Analgesics Product Offered
13.7.3 Pfizer, Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pfizer, Inc. Main Business Overview
13.7.5 Pfizer, Inc. Latest Developments
13.8 Reckitt Benckiser Group
13.8.1 Reckitt Benckiser Group Company Information
13.8.2 Reckitt Benckiser Group Transdermal Analgesics Product Offered
13.8.3 Reckitt Benckiser Group Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Reckitt Benckiser Group Main Business Overview
13.8.5 Reckitt Benckiser Group Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Transdermal Analgesics Product Offered
13.9.3 Sanofi Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Transdermal Analgesics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Transdermal Analgesics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Non opioids
Table 4. Major Players of Opioids
Table 5. Global Transdermal Analgesics Sales by Type (2017-2022) & (K Units)
Table 6. Global Transdermal Analgesics Sales Market Share by Type (2017-2022)
Table 7. Global Transdermal Analgesics Revenue by Type (2017-2022) & ($ million)
Table 8. Global Transdermal Analgesics Revenue Market Share by Type (2017-2022)
Table 9. Global Transdermal Analgesics Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Transdermal Analgesics Sales by Application (2017-2022) & (K Units)
Table 11. Global Transdermal Analgesics Sales Market Share by Application (2017-2022)
Table 12. Global Transdermal Analgesics Revenue by Application (2017-2022)
Table 13. Global Transdermal Analgesics Revenue Market Share by Application (2017-2022)
Table 14. Global Transdermal Analgesics Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Transdermal Analgesics Sales by Company (2020-2022) & (K Units)
Table 16. Global Transdermal Analgesics Sales Market Share by Company (2020-2022)
Table 17. Global Transdermal Analgesics Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Transdermal Analgesics Revenue Market Share by Company (2020-2022)
Table 19. Global Transdermal Analgesics Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Transdermal Analgesics Producing Area Distribution and Sales Area
Table 21. Players Transdermal Analgesics Products Offered
Table 22. Transdermal Analgesics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Transdermal Analgesics Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Transdermal Analgesics Sales Market Share Geographic Region (2017-2022)
Table 27. Global Transdermal Analgesics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Transdermal Analgesics Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Transdermal Analgesics Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Transdermal Analgesics Sales Market Share by Country/Region (2017-2022)
Table 31. Global Transdermal Analgesics Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Transdermal Analgesics Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Transdermal Analgesics Sales by Country (2017-2022) & (K Units)
Table 34. Americas Transdermal Analgesics Sales Market Share by Country (2017-2022)
Table 35. Americas Transdermal Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Transdermal Analgesics Revenue Market Share by Country (2017-2022)
Table 37. Americas Transdermal Analgesics Sales by Type (2017-2022) & (K Units)
Table 38. Americas Transdermal Analgesics Sales Market Share by Type (2017-2022)
Table 39. Americas Transdermal Analgesics Sales by Application (2017-2022) & (K Units)
Table 40. Americas Transdermal Analgesics Sales Market Share by Application (2017-2022)
Table 41. APAC Transdermal Analgesics Sales by Region (2017-2022) & (K Units)
Table 42. APAC Transdermal Analgesics Sales Market Share by Region (2017-2022)
Table 43. APAC Transdermal Analgesics Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Transdermal Analgesics Revenue Market Share by Region (2017-2022)
Table 45. APAC Transdermal Analgesics Sales by Type (2017-2022) & (K Units)
Table 46. APAC Transdermal Analgesics Sales Market Share by Type (2017-2022)
Table 47. APAC Transdermal Analgesics Sales by Application (2017-2022) & (K Units)
Table 48. APAC Transdermal Analgesics Sales Market Share by Application (2017-2022)
Table 49. Europe Transdermal Analgesics Sales by Country (2017-2022) & (K Units)
Table 50. Europe Transdermal Analgesics Sales Market Share by Country (2017-2022)
Table 51. Europe Transdermal Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Transdermal Analgesics Revenue Market Share by Country (2017-2022)
Table 53. Europe Transdermal Analgesics Sales by Type (2017-2022) & (K Units)
Table 54. Europe Transdermal Analgesics Sales Market Share by Type (2017-2022)
Table 55. Europe Transdermal Analgesics Sales by Application (2017-2022) & (K Units)
Table 56. Europe Transdermal Analgesics Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Transdermal Analgesics Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Transdermal Analgesics Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Transdermal Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Transdermal Analgesics Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Transdermal Analgesics Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Transdermal Analgesics Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Transdermal Analgesics Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Transdermal Analgesics Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Transdermal Analgesics
Table 66. Key Market Challenges & Risks of Transdermal Analgesics
Table 67. Key Industry Trends of Transdermal Analgesics
Table 68. Transdermal Analgesics Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Transdermal Analgesics Distributors List
Table 71. Transdermal Analgesics Customer List
Table 72. Global Transdermal Analgesics Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Transdermal Analgesics Sales Market Forecast by Region
Table 74. Global Transdermal Analgesics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Transdermal Analgesics Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Transdermal Analgesics Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Transdermal Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Transdermal Analgesics Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Transdermal Analgesics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Transdermal Analgesics Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Transdermal Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Transdermal Analgesics Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Transdermal Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Transdermal Analgesics Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Transdermal Analgesics Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Transdermal Analgesics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Transdermal Analgesics Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Transdermal Analgesics Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Transdermal Analgesics Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Transdermal Analgesics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Transdermal Analgesics Revenue Market Share Forecast by Application (2023-2028)
Table 92. Abbott Laboratories Basic Information, Transdermal Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Laboratories Transdermal Analgesics Product Offered
Table 94. Abbott Laboratories Transdermal Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Abbott Laboratories Main Business
Table 96. Abbott Laboratories Latest Developments
Table 97. AbbVie Inc. Basic Information, Transdermal Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 98. AbbVie Inc. Transdermal Analgesics Product Offered
Table 99. AbbVie Inc. Transdermal Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. AbbVie Inc. Main Business
Table 101. AbbVie Inc. Latest Developments
Table 102. Bayer AG Basic Information, Transdermal Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer AG Transdermal Analgesics Product Offered
Table 104. Bayer AG Transdermal Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Eli Lilly and Company Basic Information, Transdermal Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 108. Eli Lilly and Company Transdermal Analgesics Product Offered
Table 109. Eli Lilly and Company Transdermal Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Eli Lilly and Company Main Business
Table 111. Eli Lilly and Company Latest Developments
Table 112. endo pharmaceuticals, Glaxosmithkline plc Basic Information, Transdermal Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 113. endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Product Offered
Table 114. endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. endo pharmaceuticals, Glaxosmithkline plc Main Business
Table 116. endo pharmaceuticals, Glaxosmithkline plc Latest Developments
Table 117. johnson and johnson md&d Basic Information, Transdermal Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 118. johnson and johnson md&d Transdermal Analgesics Product Offered
Table 119. johnson and johnson md&d Transdermal Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. johnson and johnson md&d Main Business
Table 121. johnson and johnson md&d Latest Developments
Table 122. Pfizer, Inc. Basic Information, Transdermal Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 123. Pfizer, Inc. Transdermal Analgesics Product Offered
Table 124. Pfizer, Inc. Transdermal Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Pfizer, Inc. Main Business
Table 126. Pfizer, Inc. Latest Developments
Table 127. Reckitt Benckiser Group Basic Information, Transdermal Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 128. Reckitt Benckiser Group Transdermal Analgesics Product Offered
Table 129. Reckitt Benckiser Group Transdermal Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Reckitt Benckiser Group Main Business
Table 131. Reckitt Benckiser Group Latest Developments
Table 132. Sanofi Basic Information, Transdermal Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 133. Sanofi Transdermal Analgesics Product Offered
Table 134. Sanofi Transdermal Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Sanofi Main Business
Table 136. Sanofi Latest Developments
List of Figures
Figure 1. Picture of Transdermal Analgesics
Figure 2. Transdermal Analgesics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transdermal Analgesics Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Transdermal Analgesics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Transdermal Analgesics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Non opioids
Figure 10. Product Picture of Opioids
Figure 11. Global Transdermal Analgesics Sales Market Share by Type in 2021
Figure 12. Global Transdermal Analgesics Revenue Market Share by Type (2017-2022)
Figure 13. Transdermal Analgesics Consumed in Hospital
Figure 14. Global Transdermal Analgesics Market: Hospital (2017-2022) & (K Units)
Figure 15. Transdermal Analgesics Consumed in Pharmacy
Figure 16. Global Transdermal Analgesics Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Transdermal Analgesics Consumed in Family
Figure 18. Global Transdermal Analgesics Market: Family (2017-2022) & (K Units)
Figure 19. Global Transdermal Analgesics Sales Market Share by Application (2017-2022)
Figure 20. Global Transdermal Analgesics Revenue Market Share by Application in 2021
Figure 21. Transdermal Analgesics Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Transdermal Analgesics Revenue Market Share by Company in 2021
Figure 23. Global Transdermal Analgesics Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Transdermal Analgesics Revenue Market Share by Geographic Region in 2021
Figure 25. Global Transdermal Analgesics Sales Market Share by Region (2017-2022)
Figure 26. Global Transdermal Analgesics Revenue Market Share by Country/Region in 2021
Figure 27. Americas Transdermal Analgesics Sales 2017-2022 (K Units)
Figure 28. Americas Transdermal Analgesics Revenue 2017-2022 ($ Millions)
Figure 29. APAC Transdermal Analgesics Sales 2017-2022 (K Units)
Figure 30. APAC Transdermal Analgesics Revenue 2017-2022 ($ Millions)
Figure 31. Europe Transdermal Analgesics Sales 2017-2022 (K Units)
Figure 32. Europe Transdermal Analgesics Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Transdermal Analgesics Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Transdermal Analgesics Revenue 2017-2022 ($ Millions)
Figure 35. Americas Transdermal Analgesics Sales Market Share by Country in 2021
Figure 36. Americas Transdermal Analgesics Revenue Market Share by Country in 2021
Figure 37. United States Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Transdermal Analgesics Sales Market Share by Region in 2021
Figure 42. APAC Transdermal Analgesics Revenue Market Share by Regions in 2021
Figure 43. China Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Transdermal Analgesics Sales Market Share by Country in 2021
Figure 50. Europe Transdermal Analgesics Revenue Market Share by Country in 2021
Figure 51. Germany Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Transdermal Analgesics Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Transdermal Analgesics Revenue Market Share by Country in 2021
Figure 58. Egypt Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Transdermal Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Transdermal Analgesics in 2021
Figure 64. Manufacturing Process Analysis of Transdermal Analgesics
Figure 65. Industry Chain Structure of Transdermal Analgesics
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)